We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AMPAC Warned for Conditions at API Manufacturing Site
AMPAC Warned for Conditions at API Manufacturing Site
August 2, 2010
AMPAC Fine Chemicals has been handed an FDA warning letter for conditions at its active pharmaceutical ingredient (API) manufacturing facility.